• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

细胞DNA含量——上皮性卵巢癌的一个稳定特征。

Cellular DNA content--a stable feature in epithelial ovarian cancer.

作者信息

Friedlander M L, Taylor I W, Russell P, Tattersall M H

出版信息

Br J Cancer. 1984 Feb;49(2):173-9. doi: 10.1038/bjc.1984.29.

DOI:10.1038/bjc.1984.29
PMID:6696818
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1976707/
Abstract

Detailed flow cytometric analysis of cellular DNA content was performed on neoplastic tissue from 33 patients with malignant common epithelial ovarian tumours in order to investigate the intratumoral stability of ploidy and proliferative fraction. There was a remarkable stability, both spatial and temporal, in the DNA pattern for any particular tumour. Of 24 tumours that were analysed in multiple areas tumour ploidy was found to be a stable marker in all but 3 cases where regional variations were evident. In 9 patients serial analyses were performed on tumour obtained either at initial diagnosis (6 patients) or second look laparotomy (3 patients) and then some time later (7-17 months) at relapse or death and in all cases the tumour ploidy remained unchanged. In addition, 10 ovarian carcinomas established in nude mice have maintained a DNA content during serial passage similar to that of the original implanted tumour. In contrast in 50% of tumours that were evaluable for S-phase analysis we demonstrated a considerable intratumoral variability in the S-phase fraction. We conclude that cellular DNA content is a stable feature of ovarian carcinoma while S-phase fraction is commonly subject to intratumoral variation.

摘要

为了研究恶性常见上皮性卵巢肿瘤的肿瘤内倍体稳定性和增殖分数,对33例恶性常见上皮性卵巢肿瘤患者的肿瘤组织进行了细胞DNA含量的详细流式细胞术分析。对于任何特定肿瘤,DNA模式在空间和时间上都具有显著的稳定性。在对多个区域进行分析的24个肿瘤中,除3例有明显区域差异的病例外,其余所有病例的肿瘤倍体均为稳定标记。对9例患者在初次诊断时(6例患者)或二次探查剖腹术时(3例患者)获取的肿瘤进行了系列分析,然后在复发或死亡时(7 - 17个月后)进行了分析,所有病例中肿瘤倍体均保持不变。此外,在裸鼠中建立的10例卵巢癌在连续传代过程中保持了与原始植入肿瘤相似的DNA含量。相比之下,在可进行S期分析的肿瘤中,50%的肿瘤显示出S期分数存在相当大的肿瘤内变异性。我们得出结论,细胞DNA含量是卵巢癌的一个稳定特征,而S期分数通常会受到肿瘤内变异的影响。

相似文献

1
Cellular DNA content--a stable feature in epithelial ovarian cancer.细胞DNA含量——上皮性卵巢癌的一个稳定特征。
Br J Cancer. 1984 Feb;49(2):173-9. doi: 10.1038/bjc.1984.29.
2
Flow cytometric analysis of DNA content in human ovarian cancers.人卵巢癌DNA含量的流式细胞术分析
Br J Cancer. 1989 Jul;60(1):45-50. doi: 10.1038/bjc.1989.217.
3
Ovarian tumour xenografts in the study of the biology of human epithelial ovarian cancer.卵巢肿瘤异种移植在人类上皮性卵巢癌生物学研究中的应用
Br J Cancer. 1985 Mar;51(3):319-33. doi: 10.1038/bjc.1985.44.
4
Influence of cellular DNA content on survival in ovarian carcinoma.细胞DNA含量对卵巢癌生存率的影响。
Obstet Gynecol. 1989 Aug;74(2):200-4.
5
Flow cytometric analysis of DNA and cell proliferation in ovarian tumors.卵巢肿瘤中DNA和细胞增殖的流式细胞术分析。
Cancer. 1988 Jan 1;61(1):121-5. doi: 10.1002/1097-0142(19880101)61:1<121::aid-cncr2820610121>3.0.co;2-n.
6
DNA ploidy analysis of borderline epithelial ovarian tumours.
J Pak Med Assoc. 2000 Oct;50(10):349-51.
7
Flow cytometric analysis of cellular DNA content as an adjunct to the diagnosis of ovarian tumours of borderline malignancy.细胞DNA含量的流式细胞术分析作为交界性恶性卵巢肿瘤诊断的辅助手段。
Pathology. 1984 Jul;16(3):301-6. doi: 10.3109/00313028409068541.
8
Long-term survival and DNA ploidy in advanced epithelial ovarian cancer.晚期上皮性卵巢癌的长期生存与DNA倍性
J Surg Oncol. 1997 Apr;64(4):299-303. doi: 10.1002/(sici)1096-9098(199704)64:4<299::aid-jso9>3.0.co;2-4.
9
Multivariate analysis of the prognostic significance of DNA-ploidy and S-phase fraction in ovarian cancer determined by flow cytometry following detection of cytokeratin-labeled tumor cells.在检测细胞角蛋白标记的肿瘤细胞后,通过流式细胞术对卵巢癌中DNA倍性和S期分数的预后意义进行多变量分析。
Gynecol Oncol. 2002 Jan;84(1):21-31. doi: 10.1006/gyno.2001.6440.
10
Proliferating cell nuclear antigen (PCNA) and Ki-67 in epithelial ovarian tumours: correlation with DNA flow cytometric analysis.
Adv Clin Path. 2001 Jan;5(1-2):3-9.

引用本文的文献

1
Investigating the Role of DNA Ploidy and Proliferation Index in Distinguishing Ameloblastoma from Ameloblastic Carcinoma.研究DNA倍体和增殖指数在鉴别成釉细胞瘤和成釉细胞癌中的作用。
Head Neck Pathol. 2025 Jan 30;19(1):13. doi: 10.1007/s12105-024-01742-2.
2
Multivariate analyses of DNA index, p62c-myc, and clinicopathological status of patients with ovarian cancer.卵巢癌患者DNA指数、p62c-myc与临床病理状态的多变量分析。
J Clin Pathol. 1998 Jun;51(6):455-61. doi: 10.1136/jcp.51.6.455.
3
Clinical and biological significance of aneuploidy in human tumours.人类肿瘤中非整倍体的临床及生物学意义。
J Clin Pathol. 1984 Sep;37(9):961-74. doi: 10.1136/jcp.37.9.961.
4
DNA index of ovarian carcinomas from 56 patients: in vivo in vitro studies.56例卵巢癌患者的DNA指数:体内外研究
Br J Cancer. 1985 Oct;52(4):565-73. doi: 10.1038/bjc.1985.228.
5
Tumour ploidy, response and survival in patients receiving endocrine therapy for advanced breast cancer.晚期乳腺癌患者接受内分泌治疗时的肿瘤倍体、反应及生存情况
Br J Cancer. 1985 Apr;51(4):573-6. doi: 10.1038/bjc.1985.80.
6
Flow cytometric analysis of DNA content in human ovarian cancers.人卵巢癌DNA含量的流式细胞术分析
Br J Cancer. 1989 Jul;60(1):45-50. doi: 10.1038/bjc.1989.217.
7
Tumour cell activity markers in epithelial ovarian cancer: are biochemical and cytometric indices complementary?上皮性卵巢癌中的肿瘤细胞活性标志物:生化指标和细胞计量指标是否具有互补性?
Br J Cancer. 1990 May;61(5):755-8. doi: 10.1038/bjc.1990.168.
8
DNA ploidy of primary hepatocellular carcinoma and pulmonary metastases.原发性肝细胞癌及肺转移灶的DNA倍体
Clin Exp Metastasis. 1992 Sep;10(5):337-44. doi: 10.1007/BF00058173.

本文引用的文献

1
FMFPAK1: a program package for routine analysis of single parameter flow microfluorimetric data on a low cost mini-computer.
Comput Biomed Res. 1980 Oct;13(5):417-29. doi: 10.1016/0010-4809(80)90039-7.
2
DNA content and kinetic characteristics of non-Hodgkin's lymphoma: determined by flow cytometry and autoradiography.非霍奇金淋巴瘤的DNA含量及动力学特征:通过流式细胞术和放射自显影术测定
Cytometry. 1981 Nov;2(3):185-8. doi: 10.1002/cyto.990020310.
3
Cytometric evidence of cytogenetic and proliferative heterogeneity of human solid tumors.人类实体瘤细胞遗传学和增殖异质性的细胞计量学证据。
Cytometry. 1982 Mar;2(5):303-8. doi: 10.1002/cyto.990020507.
4
Identification and quantitation of tumour cells in cell suspensions: a comparison of cytology and flow cytometry.细胞悬液中肿瘤细胞的鉴定与定量:细胞学与流式细胞术的比较
Br J Cancer. 1981 Apr;43(4):526-31. doi: 10.1038/bjc.1981.75.
5
DNA distribution in human colon carcinomas and its relationship to clinical behavior.DNA在人类结肠癌中的分布及其与临床行为的关系。
J Natl Cancer Inst. 1982 Jul;69(1):15-22.
6
Flow cytometric and morphological studies of ovarian carcinoma cell lines and xenografts.卵巢癌细胞系和异种移植瘤的流式细胞术及形态学研究
Cancer Res. 1983 Aug;43(8):3725-31.
7
Tumor progression studied by analysis of cellular features of serial ascitic ovarian carcinoma tumors.通过分析系列腹水型卵巢癌肿瘤的细胞特征来研究肿瘤进展。
Cancer Res. 1983 Feb;43(2):874-8.
8
Flow cytometric analysis of DNA content of bone marrow cells in patients with plasma cell myeloma: clinical implications.浆细胞骨髓瘤患者骨髓细胞DNA含量的流式细胞术分析:临床意义
Blood. 1982 Mar;59(3):528-35.
9
Flow cytometry of DNA content in human bone marrow: a critical reappraisal.人骨髓中DNA含量的流式细胞术:一项批判性重新评估。
Blood. 1980 May;55(5):734-40.
10
The influence of age on the DNA ploidy levels of breast tumours.年龄对乳腺肿瘤DNA倍体水平的影响。
Eur J Cancer Clin Oncol. 1983 May;19(5):623-8. doi: 10.1016/0277-5379(83)90178-5.